Stocktoria
CUMBERLAND PHARMACEUTICALS INC CPIX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-08-11
CUMBERLAND PHARMACEUTICALS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $44.5M | $37.9M | $39.6M | $42.0M | $36.0M |
| R&D expense | $5.6M | $4.8M | $5.8M | $6.7M | $5.7M |
| Operating income | -$2.8M | -$6.4M | -$9.6M | -$5.7M | -$7.7M |
| Interest expense | $495,990 | $605,508 | $667,861 | $585,995 | $98,031 |
| Income tax | $40,256 | -$22,669 | $45,769 | $68,850 | $34,891 |
| Net income | -$2.8M | -$6.5M | -$6.3M | -$5.6M | -$3.5M |
| EPS (diluted) | $-0.19 | $-0.46 | $-0.44 | $-0.38 | $-0.24 |
| Operating cash flow | $4.9M | -$612,186 | $6.1M | $8.5M | $6.3M |
| Free cash flow | $4.8M | -$678,647 | $5.8M | $8.4M | $6.2M |
| Cash & equivalents | $11.4M | $18.0M | $18.3M | $19.8M | $27.0M |
| Inventory | $6.2M | $4.0M | $4.6M | $9.9M | $8.4M |
| Total assets | $76.8M | $75.6M | $81.8M | $92.9M | $84.5M |
| Total liabilities | $52.3M | $53.0M | $52.5M | $57.0M | $41.9M |
| Shareholders' equity | $24.9M | $22.9M | $29.6M | $36.3M | $42.8M |
Source: SEC EDGAR filings · CIK 0001087294 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.